Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 4/20 | 0.53 |
| ▸ | MAP1LC3A | Q9H492 | 4/20 | 0.53 |
| ▸ | HSD17B3 | P37058 | 3/20 | 0.52 |
| ▸ | NQO1 | P15559 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PDE2A | O00408 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8488462 | 1.00 | MAP1LC3B (0.53) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL6277138 | 1.00 | MAP1LC3B (0.53) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL8489872 | 1.00 | MAP1LC3B (0.53) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL8488403 | 0.99 | MAP1LC3B (0.53) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL6276622 | 0.95 | MAP1LC3B (0.57) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL8489977 | 0.91 | HSD17B3 (0.53) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL8492040 | 0.91 | NQO1 (0.55) | MAP1LC3BMAP1LC3AHSD17B3NQO1ALDH1A1 | |
| SCHEMBL8494936 | 0.90 | ALOX15 (0.51) | MAP1LC3BMAP1LC3AHSD17B3PGAM1 | |
| SCHEMBL6272846 | 0.90 | ALOX15 (0.51) | MAP1LC3BMAP1LC3AHSD17B3PGAM1 | |
| SCHEMBL6274447 | 0.90 | ALOX15 (0.51) | MAP1LC3BMAP1LC3AHSD17B3PGAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1307991-C | Benzopyrany/derivatives and antiallergic agent | DAINIPPON INK & CHEMICALS (JP) | 2007-04-04 | — | — | CN | disclosed |
| EP-1273578-B1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK & CHEMICALS (JP) | 2005-02-23 | — | — | EP | disclosed |
| CN-1473565-A | Benzopyrany/derivatives and antiallergic agent | ���ձ���ī��ѧ��ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| US-6670391-B2 | For inhibiting both immediate and delayed type allergic reactions; side effect reduction | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-12-30 | — | — | US | disclosed |
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-05-22 | — | — | US | disclosed |
| CN-1101678-C | Benzopyran derivative and therapeutic agent for heart disease containing the same as active ingredient | DAINIPPON INK & CHEMICALS (JP) | 2003-02-19 | — | — | CN | disclosed |
| EP-1273578-A1 | Benzopyran derivatives and antiallergic agent containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-01-08 | — | — | EP | disclosed |
| EP-0796854-B1 | Benzopyran derivative and use of said benzopyran derivative for treating heart disease | DAINIPPON INK & CHEMICALS (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-5981495-A | TREATING HEART DISEASE BY ADMINISTERING TO THE HEART PATIENT A BENOPYRAN DERIVATIVE | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-11-09 | — | — | US | disclosed |
| CN-1164999-A | Benzopyran derivative and therapeutic agent for heart disease containing the same as active ingredient | DAINIPPON INK & CHEMICALS (JP) | 1997-11-19 | — | — | CN | disclosed |
| EP-0796854-A1 | Benzopyran derivative and use of said benzopyran derivative for treating heart disease | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096860-A1 | Benzopyran derivative and antiallergic agent | HRH2, HRH1, HRH4 | MAP1LC3B 4772/4885MAP1LC3A 4614/4885HSD17B3 1061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.